Skip to content

Drug interactions

Fexinidazole + Montelukast

Severity: Minor

Fexinidazole and Montelukast: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fexinidazole may inhibit CYP3A4, but montelukast is mainly cleared by CYP2C8 with contributions from CYP3A4 and CYP2C9, so a large rise in exposure is unlikely. Montelukast has a wide therapeutic margin, so any increase is likely to be of little clinical consequence.

What this interaction means in plain words

Fexinidazole and Montelukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Possible CYP3A4 inhibition by fexinidazole slightly reducing a minor montelukast clearance pathway.

What to do

No dose change is needed; monitor for montelukast adverse effects such as headache or neuropsychiatric symptoms.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fexinidazole and Montelukast, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fexinidazole with Montelukast?

MediHelp rates the interaction as minor. Fexinidazole and Montelukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Fexinidazole may inhibit CYP3A4, but montelukast is mainly cleared by CYP2C8 with contributions from CYP3A4 and CYP2C9, so a large rise in exposure is unlikely. Montelukast has a wide therapeutic margin, so any increase is likely to be of little clinical consequence.

How serious is the interaction between Fexinidazole and Montelukast?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is needed; monitor for montelukast adverse effects such as headache or neuropsychiatric symptoms.

What other medicines interact with Montelukast?

MediHelp also lists interactions of Montelukast with, for example, Apalutamide, Carbamazepine, Deferasirox. The full list is on the Montelukast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in